<VariationArchive VariationID="1709877" VariationName="NM_001904.4(CTNNB1):c.1185+1dup" VariationType="Duplication" Accession="VCV001709877" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-08" DateCreated="2022-10-15" MostRecentSubmission="2022-10-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1708230" VariationID="1709877">
      <GeneList>
        <Gene Symbol="CTNNB1" FullName="catenin beta 1" GeneID="1499" HGNC_ID="HGNC:2514" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="41199505" stop="41240443" display_start="41199505" display_stop="41240443" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="41240941" stop="41281938" display_start="41240941" display_stop="41281938" Strand="+" />
          </Location>
          <OMIM>116806</OMIM>
          <Haploinsufficiency last_evaluated="2017-11-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CTNNB1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-11-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CTNNB1">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="LOC126806659" FullName="BRD4-independent group 4 enhancer GRCh37_chr3:41274918-41276117" GeneID="126806659" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3p22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="41233427" stop="41234626" display_start="41233427" display_stop="41234626" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_001904.4(CTNNB1):c.1185+1dup</Name>
      <CanonicalSPDI>NC_000003.12:41233443:GG:GGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3p22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="41233443" stop="41233444" display_start="41233443" display_stop="41233444" variantLength="1" positionVCF="41233443" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="41274934" stop="41274935" display_start="41274934" display_stop="41274935" variantLength="1" positionVCF="41274934" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1108t1" sequenceAccession="LRG_1108t1">
            <Expression>LRG_1108t1:c.1185+1dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001904.4" sequenceAccession="NM_001904" sequenceVersion="4" change="c.1184_1185insG" MANESelect="true">
            <Expression>NM_001904.4:c.1184_1185insG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.41274936dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.41274936dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.41233445dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.41233445dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013302.2" sequenceAccession="NG_013302" sequenceVersion="2" change="g.38995dup">
            <Expression>NG_013302.2:g.38995dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_082979.1" sequenceAccession="NG_082979" sequenceVersion="1" change="g.119dup">
            <Expression>NG_082979.1:g.119dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330729.2" sequenceAccession="NM_001330729" sequenceVersion="2" change="c.1164+1dup">
            <Expression>NM_001330729.2:c.1164+1dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001904.4" sequenceAccession="NM_001904" sequenceVersion="4" change="c.1185+1dup" MANESelect="true">
            <Expression>NM_001904.4:c.1185+1dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001098209.2" sequenceAccession="NM_001098209" sequenceVersion="2" change="c.1185+1dup">
            <Expression>NM_001098209.2:c.1185+1dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001098210.2" sequenceAccession="NM_001098210" sequenceVersion="2" change="c.1185+1dup">
            <Expression>NM_001098210.2:c.1185+1dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1108" sequenceAccession="LRG_1108">
            <Expression>LRG_1108:g.38995dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001904.4(CTNNB1):c.1185+1dup AND Severe intellectual disability-progressive spastic diplegia syndrome" Accession="RCV002290219" Version="2">
        <ClassifiedConditionList TraitSetID="9236">
          <ClassifiedCondition DB="MedGen" ID="C3554449">Severe intellectual disability-progressive spastic diplegia syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-08-12" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-10-15" MostRecentSubmission="2022-10-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="9236" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17594" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS</ElementValue>
                <XRef Type="MIM" ID="615075" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0020" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0018" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0022" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="116806.0023" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe intellectual disability-progressive spastic diplegia syndrome</ElementValue>
                <XRef ID="MONDO:0014035" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NEDSDV</ElementValue>
                <XRef Type="MIM" ID="615075" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3505" />
                <XRef ID="3505" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">CTNNB1 neurodevelopmental disorder (CTNNB1-NDD) is characterized in all individuals by mild-to-profound cognitive impairment and in up to 39% of reported individuals by exudative vitreoretinopathy, an ophthalmologic finding consistent with familial exudative vitreoretinopathy (FEVR). Other common findings include truncal hypotonia, peripheral spasticity, dystonia, behavior problems, microcephaly, and refractive errors and strabismus. Less common features include intrauterine growth restriction, feeding difficulties, and scoliosis.</Attribute>
                <XRef ID="NBK580527" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">35593792</ID>
                <ID Source="BookShelf">NBK580527</ID>
              </Citation>
              <XRef ID="404473" DB="Orphanet" />
              <XRef ID="C3554449" DB="MedGen" />
              <XRef ID="MONDO:0014035" DB="MONDO" />
              <XRef Type="MIM" ID="615075" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5043574" SubmissionDate="2022-10-06" DateLastUpdated="2022-10-15" DateCreated="2022-10-15">
        <ClinVarSubmissionID localKey="NM_001904.4:c.1184_1185insG|OMIM:615075" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002579401" DateUpdated="2022-10-15" DateCreated="2022-10-15" Type="SCV" Version="1" SubmitterName="MGZ Medical Genetics Center" OrgID="255845" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTNNB1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001904.4:c.1184_1185insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615075" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>ACMG criteria applied: PVS1, PS2, PM2_SUP</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12035528</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5043574" TraitType="Disease" MappingType="XRef" MappingValue="615075" MappingRef="OMIM">
        <MedGen CUI="C3554449" Name="Severe intellectual disability-progressive spastic diplegia syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

